These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15243045)

  • 1. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations.
    van Dyck E; Buvé A; Weiss HA; Glynn JR; Brown DW; De Deken B; Parry J; Hayes RJ
    J Clin Microbiol; 2004 Jul; 42(7):2961-5. PubMed ID: 15243045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.
    Biraro S; Mayaud P; Morrow RA; Grosskurth H; Weiss HA
    Sex Transm Dis; 2011 Feb; 38(2):140-7. PubMed ID: 20706175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma.
    Groen J; Hersmus B; Niesters HG; Roest W; van Dijk G; van der Meijden W; Osterhaus AD
    J Clin Virol; 1999 May; 12(3):193-200. PubMed ID: 10382816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
    Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of commercial enzyme immunoassays to detect antibodies to the herpes simplex virus type 2 glycoprotein G in a low-risk population in Hanoi, Vietnam.
    Ngo TD; Laeyendecker O; La H; Hogrefe W; Morrow RA; Quinn TC
    Clin Vaccine Immunol; 2008 Feb; 15(2):382-4. PubMed ID: 18077617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.
    Prince HE; Ernst CE; Hogrefe WR
    J Clin Lab Anal; 2000; 14(1):13-6. PubMed ID: 10645979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus.
    Martins TB; Woolstenhulme RD; Jaskowski TD; Hill HR; Litwin CM
    Am J Clin Pathol; 2001 Feb; 115(2):272-7. PubMed ID: 11211617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum.
    Groen J; Van Dijk G; Niesters HG; Van Der Meijden WI; Osterhaus AD
    J Clin Microbiol; 1998 Mar; 36(3):845-7. PubMed ID: 9508330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
    Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
    Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three commercial immunoassays for detection of herpes simplex virus type 2 antibodies in commercial sex workers in Yunnan Province, China.
    Ngo TD; Laeyendecker O; Morrow RA; Lai S; Quinn TC
    Clin Vaccine Immunol; 2008 Aug; 15(8):1301-3. PubMed ID: 18508932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.
    Lingappa J; Nakku-Joloba E; Magaret A; Friedrich D; Dragavon J; Kambugu F; Joloba M; Whalen C; Coombs R; Celum C; Morrow RA
    Int J STD AIDS; 2010 Sep; 21(9):611-6. PubMed ID: 21097732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting.
    Agyemang E; Le QA; Warren T; Magaret AS; Selke S; Johnston C; Jerome KR; Wald A
    Sex Transm Dis; 2017 Dec; 44(12):763-767. PubMed ID: 28876290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.
    Patel EU; Manucci J; Kahle EM; Lingappa JR; Morrow RA; Piwowar-Manning E; James A; Maluzi KF; Cheeba MM; Gray G; Kosloff B; Delany-Moretlwe S; Inambao M; Vwalika B; Quinn TC; Laeyendecker O
    BMC Infect Dis; 2015 Sep; 15():398. PubMed ID: 26423888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2.
    Binnicker MJ; Jespersen DJ; Harring JA
    Clin Vaccine Immunol; 2010 Feb; 17(2):253-7. PubMed ID: 20007366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays.
    Liermann K; Schäfler A; Henke A; Sauerbrei A
    J Virol Methods; 2014 Apr; 199():29-34. PubMed ID: 24418499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics.
    Summerton J; Riedesel M; Laeyendecker O; Gaydos C; Maldeis NE; Hardick A; Morrow RA; Quinn TC
    Clin Vaccine Immunol; 2007 Dec; 14(12):1545-9. PubMed ID: 17913866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.
    Mujugira A; Morrow RA; Celum C; Lingappa J; Delany-Moretlwe S; Fife KH; Heffron R; De Bruyn G; Homawoo B; Karita E; Mugo N; Vwalika B; Baeten JM;
    Sex Transm Infect; 2011 Apr; 87(3):238-41. PubMed ID: 21307152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.
    Gamiel JL; Tobian AA; Laeyendecker OB; Reynolds SJ; Morrow RA; Serwadda D; Gray RH; Quinn TC
    Clin Vaccine Immunol; 2008 May; 15(5):888-90. PubMed ID: 18321879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative performance of herpes simplex virus type 2-specific serologic assays from Meridian Diagnostics and MRL diagnostics.
    Ribes JA; Hayes M; Smith A; Winters JL; Baker DJ
    J Clin Microbiol; 2001 Oct; 39(10):3740-2. PubMed ID: 11574606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
    Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
    Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.